DrStephen Wort
Professor of Practice (Pulmonary Hypertension)
National Heart & Lung Institute - Faculty of Medicine
Orcid identifier0000-0003-4287-1173 (opens in a new tab)
- Professor of Practice (Pulmonary Hypertension)National Heart & Lung Institute - Faculty of Medicine
- 020 7351 8528 (Work)
- 305, Sydney Street, Royal Brompton Campus, United Kingdom
BIO
I am clinical Lead for Pulmonary Hypertension at the Royal Brompton Hospital, which is a nationally designated centre for the treatment of pulmonary hypertension. I am also an honorary Professor of Practice with Imperial College, previously being a Reader.
My first degree was in Chemistry, awarded from the University of Oxford (1988). I was awarded a university distinction in biochemistry and college exhibition in chemistry. I studied medicine at University College Hospitals, London, and qualified in 1993. I was awarded multiple pre-clinical and clinical prizes including the Meyerstein scholarship for best overall performance in BMS I and II, MacGrath prize in Medicine and John Briffa Prize for Outstanding Academic and Extra-curricular Activities. I gained my MRCP (Royal College of Physicians of London) in 1996, and was elected as a Fellow (FRCP) in 2010. I am also a fellow of the Faculty of Intensive Care Medicine.
I was awarded a PhD in 2002 which I undertook at Imperial College London, having been successfully awarded a Wellcome Trust Clinical Research Training Fellowship. I became a Consultant in 2006, qualifying in General Medicine, Respiratory Medicine and Intensive Care Medicine (CCST).
As a Professor of Practice, I have a clinical bias although I try to maintain a healthy academic portfolio. My research interests include mechanisms of pulmonary vascular remodelling and, more recently, the clinical aspects of pulmonary hypertension associated with chronic lung disease.
I have been chair of several important national committees including the National Pulmonary Hypertension Physicians' Committee and the BTS Pulmonary Vascular SAG. I sit on the National Pulmonary Hypertension Outcomes Group and have been a member of the National Pulmonary Hypertension Audit Board. I am an active member of the Pulmonary Vascular Research Institute IDDI Group 3 PH working group. I regularly sit on advisory boards to Pharma companies such as Bayer, Janssen, MSD and Ferrer. I have received research grants from some of these companies.
I am on the Editorial boards of the European Respiratory Review, Pulmonary Circulation, Respirology and International Journal of Cardiology Congenital Heart Disease.
My first degree was in Chemistry, awarded from the University of Oxford (1988). I was awarded a university distinction in biochemistry and college exhibition in chemistry. I studied medicine at University College Hospitals, London, and qualified in 1993. I was awarded multiple pre-clinical and clinical prizes including the Meyerstein scholarship for best overall performance in BMS I and II, MacGrath prize in Medicine and John Briffa Prize for Outstanding Academic and Extra-curricular Activities. I gained my MRCP (Royal College of Physicians of London) in 1996, and was elected as a Fellow (FRCP) in 2010. I am also a fellow of the Faculty of Intensive Care Medicine.
I was awarded a PhD in 2002 which I undertook at Imperial College London, having been successfully awarded a Wellcome Trust Clinical Research Training Fellowship. I became a Consultant in 2006, qualifying in General Medicine, Respiratory Medicine and Intensive Care Medicine (CCST).
As a Professor of Practice, I have a clinical bias although I try to maintain a healthy academic portfolio. My research interests include mechanisms of pulmonary vascular remodelling and, more recently, the clinical aspects of pulmonary hypertension associated with chronic lung disease.
I have been chair of several important national committees including the National Pulmonary Hypertension Physicians' Committee and the BTS Pulmonary Vascular SAG. I sit on the National Pulmonary Hypertension Outcomes Group and have been a member of the National Pulmonary Hypertension Audit Board. I am an active member of the Pulmonary Vascular Research Institute IDDI Group 3 PH working group. I regularly sit on advisory boards to Pharma companies such as Bayer, Janssen, MSD and Ferrer. I have received research grants from some of these companies.
I am on the Editorial boards of the European Respiratory Review, Pulmonary Circulation, Respirology and International Journal of Cardiology Congenital Heart Disease.
ACADEMIC POSITIONS
- Professor of PracticeImperial College London, London, United Kingdom3 Oct 2022 - present
FACULTY
- Faculty of Medicine
POSITION NAME
- Professor of Practice (Pulmonary Hypertension)